AstraZeneca Total Liabilities and Share Holders Equity 2010-2024 | AZN

AstraZeneca total liabilities and share holders equity for the quarter ending June 30, 2024 was $104.340B, a 8.08% increase year-over-year.

  • AstraZeneca total liabilities and share holders equity for 2023 was $101.119B, a 4.8% increase from 2022.
  • AstraZeneca total liabilities and share holders equity for 2022 was $96.483B, a 8.43% decline from 2021.
  • AstraZeneca total liabilities and share holders equity for 2021 was $105.363B, a 57.9% increase from 2020.

AstraZeneca Total Liabilities and Share Holders Equity 2010-2024 | AZN

  • AstraZeneca total liabilities and share holders equity for 2023 was $101.119B, a 4.8% increase from 2022.
  • AstraZeneca total liabilities and share holders equity for 2022 was $96.483B, a 8.43% decline from 2021.
  • AstraZeneca total liabilities and share holders equity for 2021 was $105.363B, a 57.9% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B